Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: Systematic review of randomised controlled trials

British Medical Journal

Volumn 317, Issue 7173, 1998, Pages 1624-1629

  Weiner, John M ^a,b   Abramson, Michael J ^b   Puy, Robert M ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID;

ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG SAFETY; EYE DISEASE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; META ANALYSIS; NOSE AIRWAY RESISTANCE; NOSE CONGESTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SNEEZING; TREATMENT OUTCOME;

EID: 0032512287     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.317.7173.1624     Document Type: Article

References (58)

1. International Rhinitis Management Working Group. International consensus report on the diagnosis and management of rhinitis. Atltrgy 199l;l9(suppl 19):1-3I.
2. Fleming DM, Crombie LD. Prevalence of hay fever in England and Wales, BWy 19S7;291:279-83.
3. Aberg N. Astlima and allergic ihinilis in Swedish conscripts. 67m Exp Allergy 1989:19:59-63.
4. Hopper T, Jenkin M, Cailin C, Giles G. Increase in ihe self-rcjioricd prevalence of asdima and hay fever in adults over the past generation. AustJ rub Health \W)j;l):\20-4.
5. Australian Bureau of Statistics, 1989-90. National health survey. Astlima and other respiratory conditions, Australia. Commonwealth Government Printer, 1991.
6. Ziering RW. Immediate and late eflects of hay fever. PMlgrad Med 19S9;S3:183-90.
7. Calderon-Zapata MA, Davies RJ. Treatment and management of allergic rhinitis. In: Kay AB, cd. Allngy ami allngic diseases. Oxford: lilackwcll, 1997.
8. Trcnner BM. Allergies for all seasons! Allergy Asthma 1997;6:8-9.
9. Sacken D, Oxinan A (eds). Tlie Cadirmie Collaboration handlinak. Oxford: Update Software, 199G.
10. Munch EP, Solxjrg M, Norreslet TT, Mygind N. A comparative study of dexchlorphcniramine malcate sustained release tablets and budcsonide nasal spray in seasonal allergic rhinitis. Alltrgy 1983:38:517-21.
11. Besuiek KB, Kenyon GS, Cherry JR. A comparam c study of bcclomcthasonc dipropionate a(jucous nasal spray with tcrfenadine tablets in seasonal allergic rhinitis. Curr Med Res Obin 1985:9560-7.
12. Wood SF. Oral antihistaminc or nasal steroid in hay fever; a double-blind double-dummy comparative study of once daily oral astcmi/olc vs twice daily nasal bcclomclhasone dipropionatc. Clin Allrrgt 1986; 16:193-201.
13. Lancer JM, Jones AS, Stevens JC, Rcckingham E. A comparison by rhinomanomctry of beclomclhasonc and tetfcnadine in the treatment of seasonal rhinilis.yLnrvNgn/Oton987:101:330-1.
14. Juniper EF, Kline PA, Hargreavc FE, Dolo\ichJ. Comparison of Ixxlomclliasone dipropionatc aqueous nasal spray, astcmi/olc, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjnnctivitis. J Allergy Clin Immuml 1989;83:627-33.
15. Robinson AC, Cherry JR. Daly S. Double-blind cross-over irial comparing beclomclhasonc dipropionate and icifcnadine in perennial rhinitis. Clin Exp Allerg 1989;19:569-73.
16. Bunnag C, Jarconcharsri P, Wong EC. A double-blind comparison of nasal budcsonidc and oral astcmizolc for the treatment of perennial rhinitis. Allergy 1992:17:313-7.
17. Darnell R, Pecoud A, Richards DH. A double-blind comparison of flnucasone propionalc aqueous nasal spray, leifenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis lo grass pollen. Clin KcpMtergy 1991:21:114 1-50.
18. Simpson RJ. Budesonide and terfenadine, separately and in combination, in the treatment of hay fever. Ann Allergy 1991:73:497-502.
19. Van Bavel J, Findlay SR, Hainpel FG Jr, Martin BG, Ratner P, Field F-Intranasal fluticasone propionatc is more effective than tcrfcnadine tablets for seasonal allergic ihinitis. Arch Intern .\ted 199-l;151:2699-701.
20. Schocnwetter W, Lim J. Comparison of intranasal triamcinolonc acctonidc with oral loratadinc for Uie treatment of patients witli seasonal allergic rhinitis, din liter 1995; 17:179-92.
21. Bernstein DI, Crcticos PS, Busse WW, Coben R, Graft DF, Holland WC, et al. Comparison of triamcinolonc acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic ihinius. J Allergy Clin Immunol 1996:97:749-55.
22. Bronsky FA, Dockhorn RJ. Mellzer EO, Shapiro G, Boltansky 11, LaForce C, et al. Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis. J Allergy Clin /mmujM;i99G;97:915-21.
23. Brooks CD, Francom SF, Peel BG, Chinic BI, Klott KA. Spectrum of seasonal allergic rhinitis symptom relief with topical corticoid and oral antihistamine given singly or in combination. AmJ Wiinol 1990;10:193-9.
24. Géhanno P, Dcsfougeres JL. Fluticasone propionate aqucous nasal spray compared with oral loratadinc in patients with seasonal allergic ihinitis. Allergy 1997:32:4 15-50.
25. Venloei D, Charpin D, Dcsfougcrcs JL. Intranasal fluticasone once daily compared with once daily cclirizinc in the treatment of seasonal allergic ihinitis. Clin Drug Invest 1997:13:291-8.
26. Frolund L. Efficacy of an oral antihistamine, loraLidine, as compared witli a nasal steroid spray, beclomethasone dipropionate, in seasonal allergic rhinitis. Clin Ololaryngol 1991;16:527-31.
27. Jordana G, Dolovich J, Briscoe MP, Day JH, Drouin MA, Gold M, et al. Intranasal fluticasone propionate versus loratadine in die ircaimciu of adolescent patients with seasonal allergic rhinitis. / Allergy Clin Immunol 1996;97:588-95.
28. Sibbald B, Hilton S, D'Souza M. An open cross-over trial comparing two doses of astcmizolc and bcclomcthasonc dipropionate in the treatment of perennial rhinitis. Clin Allergy 1086:16203-11.
29. Andersson M, Lindqvist N, Svensson C, Fk I, Pipkorn U. Dry powder inhalation of budcsonide in allergic rhinitis. Clin Olotarytigol 1993;18:30-3.
30. Dickson DJ, Cruickshank JM. Comparison of flunisolidc nasal spray and terfcnadine tablets in hay fever. Br J Clin Pract 1981;38:416-20.
31. Backhouse CI, Finnamore VP, Gosden CW. Treatment of seasonal allergic rhinitis with flunisolide and tcrfciiadinc./ lut A led Res 19S6;14:35-41.
32. Benincasa C, Lloyd RS. Evaluation of Duticasone propionate aqueous nasal spray taken alone and in combination with cctirizinc in the prophylactic treatment of seasonal allergic rhinitis. Drag Iin'est 1991;8:225-33.
33. Drouin MA, Yang WH. Horak F, van dc Heyning PH. Kunkel GH, Backhouse CI, et al. Adding loratadine to topical nasal steroid therapy improves moderately severe seasonal allergic rhinoconjunctivitis. Adv Ther 1995:12:310-9.
34. Davies RJ, Lund VJ, Harten-Ash VJ. The effect of intranasal azclastinc and beclomclhasonc on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis. Rhinnlngy 1993;31:159-61.
35. Pelucchi A, Chiapparino A, Masuopasqua B, Marazzini L, Hernandez A, Forcsi A. Effect of intranasal a/elastine and beclomcthasone dipropionate on nasal symptoms, nasal cytology, and bronchial rcsponsivcness to mclhacholinc in allergic rhinitis in response to grass pollcns.J/U/gr Clin /mmiHio/1995;95:515-23.
36. Haiding SM, Heath H. Intranasal steroid actosol in perennial rhinitis; comparison witli an antihistamine coni[KmL Clin Allergy 1976;6:3G9-72.
37. Lau SK, Wei WI, van Hasselt CV, Sham CL, Woo J, Choa D, et al. A clinical comparison of budcsonidc nasal aerosol, tcrfenadinc and a combination therapy of budcsonidc and oxymclazoline in adult patients widi perennial rhinitis. Asian Pae J Allergy Iinmunol 1990;8:109-15.
38. Negrini AC, Troisc C, Vollolini S, Horak F, Bachcrt C, Jansscns M. Oral amihistamine/dccongcstant treatment compared \vidi intranasal corticostct oids in seasonal allergic rhinitis. Clin fa/i Allergy 1003:25:60-5.
39. Hilberg O. Effect of tcifcnadinc and budcsonidc on nasal symptoms, olfaction, and nasal airways patency following allergen challenge. Allergy 1995;50;683-8.
40. Meltzer EO. Nasal cytological changes following pliarinacological intervention. Allergy 1995;50(suppl 23):15-20.
41. Ramsdale EH, Kline PA. Comparison of an intranasal steroid (budcsonide) widi terfcnadinc in tlie treatment of ragweed-induced r!iinoconjunctivitis.y/U/frgv Clin Immunol 1990;85:244. [AbstracL]
42. Ramsdale EH, Kline PA. Comparison of once daily treatment with an aniihistaminc (loratadinc) and topical steroid (fluticasonc propionatc) during the ragweed pollen season. J Allergy Clin Immunol 1991;87:298. [Abstract]
43. Stricker W, Klimas J, Mendelson L, Morris RJ, Recel CE, Sbapiro G, et al. Intranasal fluticasone propionate is more effective than astemizole for seasonal allergic rhinitis, Ann Allergy 1994;72:8G. [Abstract]
44. Nathan RA. Changing strategics in the treatment of allergic rhinitis. Ann Allergy Asthma Immunol 199G;77:255-9.
45. Meltzer EO, Weiler JM, Widlitz MD. Comparative outdoor study of the efficacy, onset and duration of action, and safety of cctirizine, loratadine, and placelxi for seasonal allergic rhinitis. J Allergy Clin Immunol 199G;97:G17-2G.
46. Munk ZM, LaForce C, Furst JA, Simpson B, Feiss G, Smith JA, et al. Efficacy and safety of triaincinolone acctonide aqueous nasal spray in patients with seasonal allergic ihinhis. Ann Allergy Asthma Immunol 1996;77:277-81.
47. Selner JC, Weber RW, Richmond GW, Stricker WE, Norton JD. Onset of action of aqueous beclomcthasone dipropionatc nasal spray in seasonal allergic rhinitis. Clin Vier 1995;17:1099-109.
48. Rak S, Jacobson MR, Sudderick RM, Masuyama K, Juliusson S, Kay AB, et al. Influence of prolonged treatment with topical corticostcroid (fluticasone propionatc) on eaily and late phase nasal responses and cellular infiltration in jthe nasal mucosa after allergen challenge. Clin Exp Allergy 1991;21:930-9.
49. Gawchick SM, Saccar CL. The use of nasal corticosteroids in allergic rhinitis. Padiatr Asthma Allergy Immunol 1993;9:25-38.
50. Pipkorn U, Pukander J, Suonpaa J, Makinen J, Lindqvist N. Long-term safety of budesonide nasal aerosol: a 5.5-ycar follow-up study. Clin Allergy 1988;18:253-9.
51. Lipworth BJ, Seckl JR. Measures for detecting systemic bioactivity with inhaled and intranasal corticostei oids. Thorax 1997;52:476-82.
52. Martinati LC, Sette L, Chiocca E, Zaninotto M, Plebani M, Boner AL. Effect of beclomcthasone dipropionaic nasal aerosol on scrum markers of bone metabolism in children with seasonal allergic rhinitis. Clin Exp Allergy 1993;23:986-91.
53. Wolthers OD, Pederson S. Knemomctric assessment of systemic activity of once daily intranasal dry-powder hudcsonide in children. Allergy 1991;49:96-9.
54. Brannan MD, Herron JM, Reidenberg P, Affrime MB. Lack of hypothalamic-pituitary-adrenal axis suppression witli once-daily or twice-daily beclomcthasone dipropionate aqueous nasal spray administered to patients with allergic rhinitis. Clin TJier 1993;17:G37-47.
55. Simons EER, Simons KJ. The pharmacology and use of H1-receptor-antagonist drugs. N Engl J Med 1991;330:1GG3-70.
56. Kozma CM, Schulz RM, Sclar DA, Krai KM, Mackowiak JI. A comparison of costs and efficacy of intranasal fluticasone and terfcnadine tablets for seasonal allergic rhinitis. Clin Ther 1996;18:334-46.
57. Berka C, Chin W. Fluticasone propionate intranasal steroid: cost-effectiveness vs antihistamincs. J Allergy Clin Immunol 1991;93:165. [AbstracL]
58. (Accepted 15 September 1998)